Rheumatoid arthritis

Rheumatoid factor isotypes in rheumatoid arthritis diagnosis and prognosis: a systematic review and meta-analysis

RMD OpenPublished Systematic review and meta-analysis

Authors' conclusion

Testing RF allows the highest sensitivity, while IgA isotype the highest specificity and positive likelihood ratio for RA diagnosis. On the other hand, determination of RF isotypes dose not allow prognostic information, as data are limited and heterogeneous.

Study context

Population
Patients in studies of rheumatoid factor (RF) isotypes in rheumatoid arthritis (RA) diagnosis and prognosis (PubMed, English, to 31 July 2022)36 articles
Participants
7,517 patients
Comparison
RF isotypes for RA diagnosis and prognosis
Outcome
Role of RF isotypes in the diagnosis and prognosis of RA
Methodological detailstwo independent assessments of quality and biases
  • Two independent assessments of quality and biases

Pooled result

As reported in the abstract

Diagnostic accuracy for RA
GroupSensitivity (highest)Specificity (highest)Positive likelihood ratio (highest)Diagnostic OR (highest)
All RF isotypes68.6% (95% CI 66.2% to 71.0%)
IgA91.4% (95% CI 90.8% to 92.0%)7.7 (95% CI 5.7 to 10.4)
IgM21.7 (95% CI 16.1 to 29.3)

Sensitivity (highest)

All RF isotypes68.6% (95% CI 66.2% to 71.0%)
IgA— not stated in the abstract
IgM— not stated in the abstract

Specificity (highest)

All RF isotypes— not stated in the abstract
IgA91.4% (95% CI 90.8% to 92.0%)
IgM— not stated in the abstract

Positive likelihood ratio (highest)

All RF isotypes— not stated in the abstract
IgA7.7 (95% CI 5.7 to 10.4)
IgM— not stated in the abstract

Diagnostic OR (highest)

All RF isotypes— not stated in the abstract
IgA— not stated in the abstract
IgM21.7 (95% CI 16.1 to 29.3)

Further pooled results

RF isotypes do not provide relevant prognostic information; results conflicting

Original publication

Rheumatoid factor isotypes in rheumatoid arthritis diagnosis and prognosis: a systematic review and meta-analysis. RMD Open. Published 4 August 2023. doi:10.1136/rmdopen-2022-002817

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.